Arglabin (Standard)

Overview

Arglabin (Standard) is the analytical standard of Arglabin ( HY-16059 ). This product is intended for research and analytical applications. Arglabin ((+)-Arglabin), a natural product isolated from Artemisia glabella, is a NLRP3 inflammasome inhibitor. Arglabin shows anti-inflammatory and antitumor activities. The antitumor activity of Arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene.

Application

Products | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > NOD-like Receptor (NLR) | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Farnesyl Transferase | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-16059R
• CAS No.: 84692-91-1
• Molecular Formula: C15H18O3
• Molecular Weight: 246.30
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source